Gulsen Kama
Insider Reports History
- Location
- San Diego, CA
- Signature
- /s/ Jonathan V. Dixon, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Gulsen Kama:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Bionano Genomics, Inc. | Chief Financial Officer | Common Stock | 16,000 | $20,320 | $1.27 | 03 Jun 2024 | Direct |
| Bionano Genomics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 75,000 | 03 Jun 2024 | Direct | ||
| Bionano Genomics, Inc. | Chief Financial Officer | No securities are beneficially owned | 0 | 11 Sep 2023 | Direct |
Insider Reports Filed by Gulsen Kama
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BNGO | Bionano Genomics, Inc. | 03 Jun 2024 | 2 | $0 | 4 | Chief Financial Officer | 05 Jun 2024, 17:48 |
| BNGO | Bionano Genomics, Inc. | 18 Sep 2023 | 1 | $0 | 4 | Chief Financial Officer | 20 Sep 2023, 17:21 |
| BNGO | Bionano Genomics, Inc. | 11 Sep 2023 | 0 | $0 | 3 | Chief Financial Officer | 20 Sep 2023, 17:14 |